Article Text
Featured editorial
Heart failure with a normal ejection fraction: new developments
Statistics from Altmetric.com
Footnotes
Competing interests GW-KY has no competing interests. MF is a consultant to Medtronic and St Jude and has a patent for perhexiline in heart failure (no current financial value). JES has received travel grants from Sanofi-Aventis, Boehringer-Ingelheim and Pfizer and lecture fees from Pfizer.
Provenance and peer review Not commissioned; not externally peer reviewed.